人5 -羟色胺受体2B:编码区多态性及其与非法药物滥用易感性的关系

Zhicheng Lin, Donna Walther, Xiao-Ying Yu, Tomas Drgon, George R Uhl
{"title":"人5 -羟色胺受体2B:编码区多态性及其与非法药物滥用易感性的关系","authors":"Zhicheng Lin,&nbsp;Donna Walther,&nbsp;Xiao-Ying Yu,&nbsp;Tomas Drgon,&nbsp;George R Uhl","doi":"10.1097/00008571-200412000-00003","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective and methods: </strong>5-Hydroxytryptamine (serotonin) receptor 2B (HTR2B) is involved in brain development. Although expressed in the human brain, HTR2B has not been investigated much for its role in higher brain functions. Here we describe a genome-scan with 391 simple sequence repeat markers in 300 Caucasians, identifying HTR2B gene as a candidate for drug abuse vulnerability.</p><p><strong>Results: </strong>From DNA re-sequencing of 110 subjects, we discovered three novel single nucleotide polymorphisms (SNPs), two of which confer a double-mutant of the receptor protein in a drug-abusing population. Arg6, a conserved basic residue, and the conserved acidic Glu42 are mutated simultaneously into Gly, termed R6G/E42G. Furthermore, this double-mutant tends to associate with drug abuse (P = 0.08 by chi2 test). The third SNP that is a synonymous mutation in the codon of Gln11 showed significant association with drug abuse (P = 0.0335 by Fisher's exact test).</p><p><strong>Conclusion: </strong>Our data are the first suggesting that HTR2B contributes to brain architecture and pathways that are involved in illegal drug reward.</p>","PeriodicalId":19917,"journal":{"name":"Pharmacogenetics","volume":"14 12","pages":"805-11"},"PeriodicalIF":0.0000,"publicationDate":"2004-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/00008571-200412000-00003","citationCount":"32","resultStr":"{\"title\":\"The human serotonin receptor 2B: coding region polymorphisms and association with vulnerability to illegal drug abuse.\",\"authors\":\"Zhicheng Lin,&nbsp;Donna Walther,&nbsp;Xiao-Ying Yu,&nbsp;Tomas Drgon,&nbsp;George R Uhl\",\"doi\":\"10.1097/00008571-200412000-00003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective and methods: </strong>5-Hydroxytryptamine (serotonin) receptor 2B (HTR2B) is involved in brain development. Although expressed in the human brain, HTR2B has not been investigated much for its role in higher brain functions. Here we describe a genome-scan with 391 simple sequence repeat markers in 300 Caucasians, identifying HTR2B gene as a candidate for drug abuse vulnerability.</p><p><strong>Results: </strong>From DNA re-sequencing of 110 subjects, we discovered three novel single nucleotide polymorphisms (SNPs), two of which confer a double-mutant of the receptor protein in a drug-abusing population. Arg6, a conserved basic residue, and the conserved acidic Glu42 are mutated simultaneously into Gly, termed R6G/E42G. Furthermore, this double-mutant tends to associate with drug abuse (P = 0.08 by chi2 test). The third SNP that is a synonymous mutation in the codon of Gln11 showed significant association with drug abuse (P = 0.0335 by Fisher's exact test).</p><p><strong>Conclusion: </strong>Our data are the first suggesting that HTR2B contributes to brain architecture and pathways that are involved in illegal drug reward.</p>\",\"PeriodicalId\":19917,\"journal\":{\"name\":\"Pharmacogenetics\",\"volume\":\"14 12\",\"pages\":\"805-11\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2004-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1097/00008571-200412000-00003\",\"citationCount\":\"32\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacogenetics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/00008571-200412000-00003\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacogenetics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/00008571-200412000-00003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 32

摘要

目的与方法:5-羟色胺(5-羟色胺)受体2B (HTR2B)参与大脑发育。尽管HTR2B在人脑中表达,但其在高级脑功能中的作用尚未得到深入研究。在这里,我们描述了对300名高加索人的391个简单序列重复标记的基因组扫描,确定HTR2B基因是药物滥用易感的候选基因。结果:从110名受试者的DNA重测序中,我们发现了三个新的单核苷酸多态性(SNPs),其中两个在吸毒人群中导致受体蛋白的双突变。保守的碱性残基Arg6和保守的酸性残基Glu42同时突变为Gly,称为R6G/E42G。此外,这种双突变倾向于与药物滥用有关(经chi2检验P = 0.08)。第三个SNP是Gln11密码子的同义突变,与药物滥用有显著相关性(Fisher精确检验P = 0.0335)。结论:我们的数据首次表明HTR2B有助于参与非法药物奖励的大脑结构和通路。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
The human serotonin receptor 2B: coding region polymorphisms and association with vulnerability to illegal drug abuse.

Objective and methods: 5-Hydroxytryptamine (serotonin) receptor 2B (HTR2B) is involved in brain development. Although expressed in the human brain, HTR2B has not been investigated much for its role in higher brain functions. Here we describe a genome-scan with 391 simple sequence repeat markers in 300 Caucasians, identifying HTR2B gene as a candidate for drug abuse vulnerability.

Results: From DNA re-sequencing of 110 subjects, we discovered three novel single nucleotide polymorphisms (SNPs), two of which confer a double-mutant of the receptor protein in a drug-abusing population. Arg6, a conserved basic residue, and the conserved acidic Glu42 are mutated simultaneously into Gly, termed R6G/E42G. Furthermore, this double-mutant tends to associate with drug abuse (P = 0.08 by chi2 test). The third SNP that is a synonymous mutation in the codon of Gln11 showed significant association with drug abuse (P = 0.0335 by Fisher's exact test).

Conclusion: Our data are the first suggesting that HTR2B contributes to brain architecture and pathways that are involved in illegal drug reward.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
In Silico Studies on Pharmacokinetics and Neuroprotective Potential of 25Mg2+: Releasing Nanocationites - Background and Perspectives Introductory Chapter: Pharmacogenetics Pharmacogenomics of “Core” Essential Medicines Methylenetetrahydrofolate reductase gene polymorphisms and response to fluorouracil-based treatment in advanced colorectal cancer patients. The human serotonin receptor 2B: coding region polymorphisms and association with vulnerability to illegal drug abuse.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1